Prevalence of arterial stiffness and the risk of myocardial diastolic
dysfunction in women by Seeland, Ute et al.
Biosci. Rep. (2016) / 36 / art:e00400 / doi 10.1042/BSR20160276
Prevalence of arterial stiffness and the risk of
myocardial diastolic dysfunction in women
Ute Seeland*†1, Anna Brecht‡, Ahmad T. Nauman*, Sabine Oertelt-Prigione*†, Mirjam Ruecke*,
Fabian Knebel‡, Verena Stangl†‡ and Vera Regitz-Zagrosek*†§
*Institute of Gender in Medicine, Charite´ University Hospital, 10115 Berlin, Germany
†German Center for Cardiovascular Research (DZHK), 10115 Berlin, Germany
‡Department of Cardiology and Angiology, Charite´ University Hospital, 10117 Berlin, Germany
§Center of Cardiovascular Research (CCR), Charite´ University Hospital, 10115 Berlin, Germany
Synopsis
The present study determines the prevalence of vascular dysfunction and arterial stiffness (ASt) in a female urban
population by measuring the brachial augmentation index (AIx) and aortic pulse wave velocity (PWV). The study
tests the hypothesis that the measurement of AIx and PWV is useful in addition to that of traditional cardiovascular
risk factors when assessing the risk for left ventricular diastolic dysfunction (LVDD). This cross-sectional study
recruited 965 women aged 25–75 years from 12 districts of Berlin. The ASt indices, brachial AIx, aortic PWV and
the central blood pressure were measured by an oscillometric method. A randomly selected subgroup (n = 343) was
examined by echocardiography. Trans-mitral inflow E/A ratio and diastolic mitral annulus velocity (e´) were assessed.
Questionnaires, medical history and blood sampling were used for the evaluation of individual risk factors. Normal
vascular function was found in 55% of the women included. The prevalence of women with pathological AIx only (AIx
 − 10%, PWV normal) was 21.5%, whereas 17.9% were affected by increased AIx and PWV (AIx  − 10%, PWV
9.7 m/s), and 6% with only pathological PWV values. The prevalence of LVDD was 31.7%. LVDD was significantly
associated with pathological PWV  9.7 m/s [OR: 1.27, 95%CI: 1.02–1.57], age [OR: 4.17, 95%CI: 2.87–6.07] and
a waist circumference >80 cm [OR: 3.61, 95%CI: 1.85–7.04] in multiple regression analysis. The high prevalence
of markers for vascular dysfunction and ASt in a general female population and their importance as a mediator of
diastolic dysfunction should encourage implementation of aortic PWV measurement to improve cardiovascular-risk
assessment in particular to identify subclinical myocardial diastolic dysfunction.
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INTRODUCTION
Detailed data about the vascular health of a general female popu-
lation in Germany determined by the non-invasive measurement
of vascular function due to the brachial augmentation index (AIx)
and the arterial stiffness (ASt) parameter aortic pulse wave ve-
locity (PWVao) are not available. The ‘Berlin Risk Evaluation
in Women’ study was performed to determine the cardiovascular
risk estimation and to measure the objective cardiovascular health
of women living in Berlin [1]. Vascular health is influenced by
many determinants, such as genetic predisposition and epigen-
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etic modifications, age, cardiovascular risk factors and gender-
specific socio-cultural circumstances. Protective conditions such
as a favourable lifestyle have a positive effect on vascular function
by powerful angioadaptive mechanisms.
The endothelium is a key regulator of vascular function [2].
Vascular dysfunction is the inability of the artery to dilate suf-
ficiently in response to an appropriate endothelial stimulus and
characterized by microvascular remodelling, decreased visco-
elastic properties of the arteries and arterioles and abnormal total
peripheral resistance (TPR) [3]. ASt of the larger arteries meas-
ured indirectly by the PWVao, is defined as the propagation of
the flow wave and the reflection of the second pulse wave at
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
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the aortic bifurcation [4]. The AIx maintains the arterial tone
and peripheral resistance, both are due to NO production and
vasomotion of the medium and small arteries [5]. The AIx is
defined as the pressure difference between the forward travelling
pulse wave and the returning pressure wave in relation to the
pulse pressure (PP), and is an indirect marker of the endothelial
function. A faster propagation of the pressure wave and a faster
return time of the second flow wave lead to the augmentation
of the first pulse wave in systole [4]. These periodically repeat-
ing processes might be associated with elevated central aortic
systolic blood pressure (SBPao) values. The Arteriograph device
allows the measurement of SBPao at the same time as AIx and
PWV [4]. The hypothesis, that the increase in left ventricular af-
terload might affect the left ventricular myocardial remodelling
with impairment of diastolic function, is supported by the fact
that elevated aortic PWV in older adults is associated with cardi-
ovascular events such as cardiovascular mortality, coronary heart
disease and stroke [6]. This issue is still a matter of debate [7].
Heart failure with preserved ejection fraction (HF-PEF) based
on myocardial diastolic dysfunction is more prevalent in women
than in men [8]. The importance of brachial AIx and aortic PWV
as markers for vascular dysfunction and ASt and the association
with asymptomatic organ damage, such as diastolic dysfunction,
was not been studied previously in a female urban population and
is the subject of the present study.
The 2013 ESC guidelines for the management of arterial hy-
pertension call for more data from large studies in different pop-
ulations to determine the potential role of the AIx and PWV
measurements [9]. The first objective of the present study is to
determine the prevalence of vascular dysfunction in a female
urban population by measuring the brachial AIx and the aortic
pulse wave velocity (PWV). The second objective is to test the
hypothesis that the measurement of AIx and PWV is useful in
addition to that of traditional cardiovascular risk factors when
assessing the risk for asymptomatic organ damage, in particu-




The Berlin Female Risk Evaluation (BEFRI) study is a
community-based cross-sectional study. German-speaking wo-
men aged 25–75 years, represented in five equal age strata and
from all 12 districts of the city of Berlin were included. We invited
3600 women to participate in the study. All women that expressed
the intention to participate (n = 1199) were sent the question-
naire, consent forms and further information materials by mail.
Of these 1066 (88.9%) agreed to participate. For measurement of
ASt indices n = 965 and for echocardiography substudy n = 473
were randomly selected proportional to the inhabitant density of
each district. Each of the five 10-year age strata accounted for
20% of the total study sample. The exclusion criteria were phys-
ical or cognitive inability to participate in the study. More details
are described in Oertelt-Prigione et al. [1]. The study was per-
formed between September 2012 and November 2013. The study
protocol was approved by the Ethics Committee of the Charite´
University Hospital Berlin (registration number: EA2/116/12)
and all research conforms to the Declaration of Helsinki.
Questionnaire
Participants were asked to answer a questionnaire to assess sev-
eral behavioural aspects of their lifestyle and medical history.
Detailed questions were asked about risk factors that play an
important role for cardiovascular risk estimation in women, e.g.
pregnancy complications, the onset of menopause and autoim-
mune diseases [10]. All patient data were pseudonymized.
Physical examination
Clinical examinations were performed, and a standardized in-
terview was conducted, focusing on the presence of acute and
chronic cardiovascular symptoms. All women were weighed, and
their waist circumference was measured in accordance with the
World Health Organizations (WHO) standards. After a 10-min
rest period, a 12-lead ECG was performed following a standard-
ized procedure (AT-10 plus, Schiller).
Measurement of arterial stiffness indices and
haemodynamic parameters
Experimental conditions were arranged according to the interna-
tional guidelines on how to conduct an investigation on arterial
vascular stiffness [11]. All measures were performed in a supine
position in a quiet, temperature-controlled room. Participants ab-
stained from coffee and tobacco use on the day of the exam and
relaxed for 10 min before initiation of the measurements. A non-
invasive oscillometric method was used for measurement of ASt
indices and haemodynamic parameters. The Arteriograph (Ten-
sioMed) has been validated invasively [4] and tested compared
with tonometric and piezo-electronic techniques (e.g. Sphygmo-
Cor and Complior) [12,13]. The device allows simultaneous re-
cordings of the ASt indices, the brachial AIx and the aortic PWV,
as well as systolic and diastolic peripheral blood pressure (SBP,
DBP), the central aortic blood pressure (SBPao) and aortic PP
during cuff occlusion of the brachial artery. Pulsatile pressure
changes in the brachial artery are detected by plethysmography,
and pressure pulse configurations are transmitted to computer
software that analyses ASt indices. The brachial AIx is calculated
from the difference in amplitude (pressure difference) between
the first and reflected second wave in relation to the PP, based on
the formula: AIx % = [(P2 − P1)/PP] × 100. The brachial AIx
levels are defined as normal (<− 10%), high ( − 10% to + 10%)
and pathological (>+ 10%) for all age strata [14,15]. Aortic AIx
correlates with brachial AIx using the regression equation y =
0.506x + 37.636 [4]. The AIx is regarded as an indirect marker
of the endothelial function which maintains the arterial tone and
peripheral resistance [5]. The aortic PWV (m/s), the time differ-
ence between the start of the first pulse wave and the beginning of
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the reflected wave, is calculated based on the formula: jugulum–
symphysis distance/(return time/2) [m/s]. The distance travelled
by the waves is assimilated as the distance between the jugulum
and the symphysis and measured individually with a tape. Aortic
PWV levels are characterized as normal (<9.7 m/s), high (9.7–
9.9 m/s) or pathological (>10 m/s) for all age strata, supported
by outcome data [14,16]. For data quality control, the standard
deviation (S.D.) was calculated from every heartbeat during a
period of 8 s, and the inclusion criterion was defined as a PWV
with a S.D. < 1.3 m/s. Three consecutive measurements were
performed and the values with the lowest S.D. (highest technical
quality) were used. The algorithm for estimating SBPao is based
on the physiological relationship between DBP, mean arterial
pressure (MAP) and peripheral and central AIx [4]. For measure-
ment of the ankle-brachial index (ABI), blood pressure was taken
from the right and left lower leg in addition to the upper arms. A
value 0.9 indicates peripheral artery disease (PAD) [17].
We categorized all women into four vascular phenotype


















Laboratory measurements were made on non-fasting blood
samples and processed within 24 h of collection. Full blood
counts, GFR (glomerular filtration rate), lipid metabolism,
HbA1c (glycated haemoglobin), BNP (B-type natriuretic pep-
tide) and sexual hormones were quantified by an external labor-
atory (Hospital Laborverbund Berlin-Brandenburg, Bernau, Ger-
many).
Standard definitions for risk factor assignment
Patients were classified according to their risk factor profile, as
determined by reported hypertension and their diabetes status.
For the definition of dyslipidaemia, the ratio of total choles-
terol (CHOL)/high-density lipoprotein cholesterol (HDL-C) was
used, with a cut-off value >5. Overweight was defined as BMI
 25 kg/m2. Waist circumference was defined as abnormal if
>80 cm. Normal ranges are 100 pg/ml for BNP and 4–6%
for HbA1c. Smoking status was coded as current, past or never.
Rheumatologic diseases, pregnancy complications and the age
of onset of menopause were asked in detail. Menopause was
defined as the absence of regular bleeding with consideration for
circumstances that could have an effect on the bleeding pattern.
Parity was defined as having any number of children. Pregnancy
complications included circulatory disorders (such as pregnancy
hypertension), pre-eclampsia, eclampsia, HELLP (haemolysis,
elevated liver enzyme levels, low platelet), premature birth, in-
trauterine growth retardation, intrauterine fetal death and pla-
cental insufficiency. Furthermore, drug names were recorded and
assigned to categories.
Echocardiography
Echocardiographic parameters were measured for studying po-
tential asymptomatic left ventricular organ damage. Standard
transthoracic echocardiography (TTE) was performed with a GE
Vivid E9 system (GE Healthcare) and an M5S probe. Data were
acquired with the subjects at rest. Examinations were performed
by experienced cardiologists according to Lang et al. [18]. Stand-
ard parameters of end-systolic and end-diastolic dimensions and
left ventricular ejection fraction (LVEF) were measured. Pulse-
wave (PW) Doppler of trans-mitral inflow was performed in the
apical 4-chamber view. Mitral inflow includes peak early filling
(E-wave) and late diastolic filling (A-wave) velocities, E/A-ratio,
deceleration time (DT) of early filling velocity and left ventricu-
lar (LV) isovolumic relaxation time (IVRT). The average septal
and lateral diastolic mitral annulus velocity (e´) was assessed by
tissue Doppler imaging (TDI) of the basal segments [19]. Dia-
stolic function was graded according to the recommendations of
the American Society of Echocardiography (ASE) [20]:
• DD0 = normal diastolic function: E/A  1, average
e´ > 9 cm/s;
• DD1 = impaired relaxation or mild DD: E/A < 1, average
e´  9 cm/s;
• DD2 = pseudonormal function or moderate DD: E/A  1,
average e´  9 cm/s.
Classification of all patients into the above three grades of
diastolic function was performed independently by two echocar-
diography experts based on all available data.
Statistical analysis
Descriptive statistics comprised medians with 25% and 75%
quantiles (IQR = interquartile range) or means and S.D. where
appropriate for continuous data and proportions for categorical
data. Differences in categorical and continuous data were de-
termined using Chi-square (χ 2), t test or ANOVA. Age-adjusted
p-values for comparing groups of vascular function/dysfunction
were calculated using multinomial regression models. Pear-
son’s correlation coefficients were used to test the correlation
between continuous, sufficiently normally distributed (mono-
modal, |skewness|<1) variables. Variables showing significant
association with the outcome variable ‘diastolic dysfunction’
were further analysed in multiple logistic regression models with
pathological characteristics as dependent variables. Results from
the multiple logistic regression analyses are presented as odds
ratios (ORs) with 95% confidence intervals (CI) and adjusted R2.
A two-sided significance level of α = 0.05 was used. Data ana-
lyses and statistical calculations were performed with SPSS 20
software.
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Table 1 Prevalence of women with normal vascular function and dysfunction
Group a: normal vascular function, group b: vascular dysfunction, group c: vascular dysfunction (VD) + arterial stiffness
and group d: arterial stiffness. Absolute numbers and percentage of total (n = 805) are shown.
AIx normal AIx high/pathological n (− 10%)
PWVao normal (a) 441 (54.8%) (b) 173 (21.5%) 614 (76.3%)
PWVao high/pathological (9.7 m/s) (d) 47 (5.8%) (c) 144 (17.9%) 191 (23.7%)
488 (60.6%) 317 (39.4%) 805 (100%)
Table 2 Distribution of normal, high and pathological values of the brachial AIx and aortic PWV
Numbers are given as absolute values and percentage of each age stratum. High brachial AIx is defined as





25–34 35–44 45–54 55–64 65–75
n = 185 n = 176 n = 158 n = 137 n = 149
AIx brachial
Normal n (%) 176 (95.1) 145 (82.4) 82 (51.9) 47 (34.3) 38 (25.5)
High n (%) 6 (3.2) 24 (13.6) 31 (19.6) 40 (29.2) 41 (27.5)
Pathological n (%) 3 (1.6) 7 (4.0) 45 (28.5) 50 (36.5) 70 (47.0)
PWVao
Normal n (%) 181 (97.8) 164 (93.2) 122 (77.2) 76 (55.5) 71 (47.7)
High n (%) 0 5 (2.8) 6 (3.8) 10 (7.3) 10 (6.7)
Pathological n (%) 4 (2.2) 7 (4.0) 30 (19.0) 51 (37.2) 68 (45.6)
RESULTS
One thousand sixty-six women participated in the ‘Berlin Risk
Evaluation in Women’ study and signed consent forms. Meas-
urements of ASt indices and haemodynamic data were made on
965 women. Data from 160 women had to be excluded because
of either an insufficient S.D. of PWV (1.3 m/s) of sequential
pulse wave velocity records or atrial fibrillation. Therefore, 805
(83%) records complied with the requirements of data quality
control. The 343 participants included in the subgroup analysis
for the measurement of LVDD were representative of the total
study cohort with regard to age strata (Supplementary flow chart).
The total cohort was categorized according to the AIx bra-
chial and aortic PWV measurements. Women with normal vas-
cular function were separated from those with vascular dysfunc-
tion. High/pathological brachial AIx values were measured in
317 women from the available sample of 805 (39.4%), and
high/pathological aortic PWV values were found in 191 (23.7%).
Although 54.8% had normal vascular function (n = 441, group
a), the prevalence of vascular dysfunction was 21.5% (n = 173,
group b). Moreover, 17.9% of the study population were af-
fected by ASt (n = 144, group c), and 47 women (5.8%, group
d) had pathological values of PWV but normal AIx (Table 1).
High/pathological AIx and PWV values were more frequently
measured in postmenopausal women. Numbers are shown in de-
tail for each age stratum in Table 2. Mean (S.D.) age at onset of
menopause was calculated to have been 49 (+−7) years.
Characteristics about age, menopausal status, medical history,
traditional and more women specific cardiovascular risk factors,
for the four vascular phenotype groups are presented in Table 3.
Age adjusted comparison of data between all groups show signi-
ficant differences in the postmenopausal status, the percentage of
women with BMI 25 kg/m2 and those with waist circumference
>80 cm.
Haemodynamic parameters were measured simultaneously
with the vascular function indices. Results are shown in Table 4
with significant differences in age adjusted values between all
groups for SBPao, mean-, systolic- and diastolic arterial pressure
and heart rate.
Myocardial diastolic dysfunction and arterial
stiffness indices
Echocardiography was performed in a representative subgroup
of 343 randomly selected women to determine LV function, in
particular diastolic function, which is related to myocardial re-
laxation, passive LV properties and the myocardial tone. The
prevalence of diastolic dysfunction (DD1 + DD2) was 31.7%
(n = 109) and 68.3% (n = 235) had normal diastolic function
(DD0). Using multiple logistic regression analysis for age adjust-
ment of the data, results show significantly higher central blood
pressure values (SBPao [mmHg] DD1 + DD2: 131.8 +− 19.5,
DD0: 114.4 +− 19.1; P = 0.036) and increased aortic PWV ([m/s]
DD1 + DD2: 9.9 +− 1.9, DD0 8.0 +− 1.6; P = 0.034) in women
with LVDD compared to women with normal myocardial func-
tion. The brachial AIx values were measured in the high range
(mean − 3.3%) in the group with diastolic dysfunction and in
normal range (mean − 26.7%) in the healthy group. However,
age adjusted p-value was not significant between the groups for
brachial AIx (Table 5).
To answer the question of the usefulness for the measurement
of brachial AIx and aortic PWV in addition to the traditional
cardiovascular risk factors with regard to the risk for LVDD,
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Table 3 Cardiovascular risk factors and medical history data by group
Numbers are given as absolute values and percentage unless otherwise stated (n = 805). Unadjusted comparisons between all groups were
calculated with ANOVA, t test or Chi-square-tests. ap-value adjusted for age using multinomial regression. MI, myocardial infarction; CAD, coronary


















n 441 173 144 47
Age mean (S.D.) 41 (12) 56 (12) 62 (9) 56 (12) <0.001 –
Postmenopausal (49 years), n (%) 92 (20.9%) 123 (71.1%) 132 (91.7%) 33 (70.2%) <0.001 0.035
Cardiovascular risk factors
Hypertension, n (%) 46 (10.5%) 52 (30.1%) 62 (43.1%) 15 (32.6%) <0.001 0.616
Diabetes mellitus, n (%) 11 (2.5%) 8 (4.6%) 10 (6.9%) 6 (12.8%) 0.004 0.190
CHOl/HDL ratio >5, n (%) 40 (9.1%) 20 (11.6%) 23 (16.0%) 5 (10.6%) 0.147 –
Current smoking, n (%) 145 (33.0%) 37 (21.5%) 30 (20.8%) 10 (22.2%) 0.004 0.568
Overweight (BMI > 25), n (%) 120 (27.2%) 53 (30.6%) 70 (48.6%) 32 (68.1%) <0.001 <0.001
Visceral fat (waist >80 cm), n (%) 127 (28.8%) 83 (48.0%) 90 (62.5%) 34 (72.3%) <0.001 0.011
Medical history
Diseases: CAD or any other: MI, PAD,
heart failure, stroke, TIA
11 (2.5%) 7 (4.0%) 11 (7.6%) 4 (8.5%) 0.016 0.240
Parity, n (%) 243 (55.1%) 129 (74.6%) 120 (83.3%) 33 (70.2%) <0.001 0.489
Pregnancy complications, n (%) 38 (8.6%) 25 (14.5%) 27 (18.8%) 7 (14.9%) 0.006 0.330
Rheumatologic diseases, n (%) 41 (9.3%) 28 (16.2%) 27 (18.8%) 12 (25.5%) <0.001 0.458
Table 4 Haemodynamic data by group
Numbers are given as mean values and standard deviation (S.D.) for n = 805. Sys, systolic blood pressure; Dia, diastolic blood pressure; HR, heart


















SBPao (mmHg) 109 (13) 136 (20) 143 (21) 125 (16) <0.001 <0.001
MAP (mmHg) 86 (11) 96 (14) 100 (14) 95 (10) <0.001 <0.001
Sys (mmHg) 118 (13) 131 (19) 137 (20) 131 (15) <0.001 <0.001
Dia (mmHg) 70 (10) 79 (13) 81 (12) 77 (9) <0.001 <0.001
PP (mmHg) 48 (8) 52 (11) 56 (12) 53 (11) <0.001 0.094
HR (min− 1) 68 (10) 65 (8) 67 (8) 79 (10) <0.001 <0.001
brachial AIx and aortic PWV have been added to the multiple
logistic regression model, with DD0 and DD1 + DD2 as the
dependent variables. Known classical cardiovascular risk factors
and other more women-specific risk factors with significant coef-
ficients in univariate analysis were added to the model. Table 6
(model 2) shows the association of age (OR: 4.17, 95%CI: 2.87–
6.07), waist circumference >80 cm (OR: 3.61, 95%CI: 1.85–
7.04) and high/pathological aortic PWV levels (OR: 1.27, 95%CI:
1.02–1.57) with LVDD.
DISCUSSION
The first stage of the cardiovascular aging continuum is the loss
of arterial vascular elasticity. Cardiovascular risk factors exacer-
bate this process and promote the development of atherosclerosis
and the premature aging of the arteries [21]. Vascular dysfunc-
tion and increased ASt are common and relevant problems of
the female general population as shown by the high prevalence
of pathological AIx with 21.5% and abnormal measurements
of PWV with 17.9% in the present study. In order to assess
whether the measurements of brachial AIx and/or aortic PWV
are associated with early asymptomatic organ damage, we meas-
ured LV diastolic function in all vascular phenotype groups:
women with normal vascular function, women with vascular
dysfunction due to increased peripheral vascular resistance and
endothelial dysfunction and women with ASt. The prevalence
of LVDD in the randomly selected study subcohort was 31.7%.
None of the women had signs of congestive heart failure. In ad-
dition to the known cardiovascular risk factor age, we identified
that high/pathological PWV 9.7 m/s and waist circumference
>80 cm, a surrogate parameter for expanded visceral fat, are
associated with LVDD. An echocardiographic examination for
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Table 5 Arterial stiffness indices and central blood pressure of women with normal diastolic function (DD0) and mild diastolic
dysfunction: impaired relaxation (DD1) and pseudonormal function (DD2)
DD0: E/A  1, average e´ > 9 cm/s; DD1: E/A < 1, average e´  9 cm/s; D2: E/A 1, e´  9 cm/s. DD1 and DD2 are calculated in one
group because of less numbers in DD2 (n = 16). e´ = average of septal and lateral diastolic mitral annulus velocity (TDI). Mean values and S.D.;









235 (68.3%) 109 (31.7%)
SBPao (mmHg) 114.4 (19.1) 131.8 (19.5) <0.001 0.036
AIx brachial (%) − 26.7 (27.8) − 3.3 (23.6) <0.001 0.127
PWVao (m/s) 8.0 (1.6) 9.9 (1.9) <0.001 0.034
PP (mmHg) 48.1 (7.8) 53.4 (10.2) <0.001 0.177
Table 6 Multiple logistic regression analysis for diastolic dysfunction
Categorical variables: hypertension, visceral fat, parity, pregnancy complications, family history of hypertension. Continuous
variables: AIx brachial, PWVao, *Age: age in decades = age in years/10. AIx brachial and PWVao were forced into the model.
Model 1 (full model)
OR (95%CI)
Model 2 (only significant variables and AIx
brachial and PWVao)
OR (95%CI)
n = 343, R2 = 0.65 n = 343, R2 = 0.63
AIx brachial 0.99 (0.97–1.00) 0.99 (0.97–1.00); P = 0.123
PWVao 1.22 (0.97–1.52) 1.27 (1.02–1.57); P = 0.033
Hypertension 1.79 (0.74–4.36) –
Visceral fat (waist > 80 cm) 2.82 (1.20–6.65) 3.61 (1.85–7.04); P<0.001
Overweight (BMI > 25 kg/m2) 1.36 (0.55–3.34) –
Parity (any no. of children) 1.97 (0.87–4.44) –
Pregnancy complications 0.37 (0.12–1.11) –
Family history hypertension 1.03 (0.48–2.18) –
Age* 4.19 (2.79–6.30) 4.17 (2.87–6.07); P<0.001
the diagnosis of diastolic dysfunction is not performed in the
clinical routine. Therefore, an easy-to-measure parameter such
as the PWV is useful in otherwise asymptomatic patients to
provide the indication for this diagnostic approach. Identifying
these women with diastolic dysfunction in an early clinical stage
is important, aiming to prevent heart failure development with
preserved ejection fraction (HF-PEF) [22,23].
Albu et al. [24] provided evidence that ASt as measured by
aortic PWV is a risk factor for LVDD in postmenopausal women,
independent of other traditional risk factors. Our study data sup-
port those findings. Yet we examined a larger cohort including
premenopausal and postmenopausal women, and we expanded
upon the number of risk factors. In addition to the classic cardi-
ovascular risk factors, the medical history of women-specific risk
factors with significant coefficients in univariate analysis – such
as pregnancy complications, parity and rheumatologic diseases –
were added to the regression analysis models. Moreover, diastolic
function was graded according to the recommendations of the
American Society of Echocardiography (ASE) including average
e´, which is highly correlated with LVDD than the E/A ratio alone.
Recently the EPOGH investigators [25] determined Doppler
indexes reflecting LV systolic and diastolic dysfunction and ASt
in 1233 randomly recruited study participants (51.7% women). In
line with the data of our study central PP, augmentation pressure
and PWV, were on average significantly higher in the diastolic
dysfunction group with elevated filling pressure when compared
to participants with normal diastolic function or with impaired re-
laxation. However, the authors did not perform a gender-specific
analysis of their data. Supported by the findings of Libhaber et
al. [26] data should be analysed by sex. They demonstrated an
association of PWV with LV mass index and LV wall thickness
independent of blood pressure and additional confounders in a
never treated population sample of women, but not men. Sex dif-
ferences of arterial characteristics and vascular function should
be considered in further studies with the aim to study sex-specific
CV-risk factors affecting AIx and PWV.
Tarnoki et al. [27] provided a further important contribution
regarding heritability of ASt. The authors measured central SBP
and ASt in 154 monozygotic and 42 dizygotic twin pairs with
Arteriograph device. They observed that age-, sex- and country-
adjusted heritability was 60% for central SBP, 50.1% for aortic
PWV and 46.8% for brachial AIx. The study data indicate that
the heritability of central SBP and the ASt indices is moderate.
Unshared environmental effects account for large portion of the
variance in this and in our study, especially for the brachial AIx
values. Further studies should focus to the role of epigenetic
modulation. These findings highlight the genetic and environ-
mental aetiology of vascular aging and the importance of early
atherosclerosis screening, detection and prevention in high-risk
patients. These findings highlight the genetic and environmental
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aetiology of vascular aging and the importance of early ath-
erosclerosis screening, detection and prevention in high-risk
patients.
The present study contains some limitations. The role of age
regarding the definition of normal- or reference values for de-
scribing the normal elasticity and impedance of the arteries, needs
careful consideration. ASt increases with age and BP; as these
are the major determinants of PWV. However, PWV values are
not simply associated with the increase in BP by age but in-
clude additional information about the function of the aortic wall
[28]. ‘Vascular’ aging is an individual and continuing process
as described by O’Rourke et al. [21]. Normal values are known
for younger people with a mean age of 33 years without any
CV-risk factors. The approach to define the exact values repres-
enting normal and abnormal PWV values by each year of age
is limited as long as outcome data of longitudinal studies are
missing. Reference values are associated with a higher risk of
early organ damage and used in the present study. We choose a
three-step scale with ‘normal’, ‘high’ and ‘pathological’ for AIx
and PWV. The limit values for pathological PWV used in the
present study correspond to these reference values of the Arterial
Stiffness Collaboration established in a European population for
subjects 50–69 years of age with grade 1 hypertension (<160/100
mmHg) and for >70 years of age with high normal blood pressure
(<140/90 mmHg) [28]. With this approach, the prevalence of wo-
men with ASt would might be underestimated in the younger age
strata. Concerning the interpretation of the study data, we are
aware that we cannot determine causality but associations and
probabilities with the cross-sectional study design.
The study data provide evidence for the association of PWV
9.7 m/s and diastolic dysfunction. This is in line with the general
expert opinion that PWV  10 m/s is associated with a high risk
for early organ damage [9].
The question that has not yet been conclusively answered is
the potential role of the brachial AIx as a risk factor for cardi-
ovascular events. The brachial AIx is a parameter for composite
vascular function, including not only static properties such as
distensibility but also dynamic ones such as endothelial func-
tion and TPR [29]. In the present study, pathological AIx was
not associated with LVDD. Assuming that pathologic AIx usu-
ally precedes pathological PWV, LVDD would not be the best
outcome variable to answer the question of the impact of AIx
on early organ damage. Another explanation could be that the
parameters AIx and PWV are more independent of each other
due to different risk factors affecting brachial AIx or aortic PWV
values. Detailed risk factor analysis would help to answer this
question and will be considered in this cohort.
Furthermore, the study data stressed the fact that measurement
of waist circumference >80 cm is associated with impaired left
ventricular diastolic function in addition to age and increased
PWV. This finding is consistent with recently data published by
Sekiguchi et al. [30]. They showed that higher waist circumfer-
ence and age are associated with abnormal LV myocardial re-
laxation in normal-weight subjects. The age-adjusted data given
in our study, confirm the association of statistically significantly
higher central blood pressure (SBPao) values of women with
diastolic dysfunction compared to those with normal myocardial
function. Recently, Herbert et al. [31] published reference val-
ues for central blood pressure (SBPao) and its amplification in a
general healthy population according to age, sex and peripheral
brachial blood pressure, with a wide geographical representation.
In summary these data support the opinion that the consider-
ation of these easy to measure parameters such as the age, waist
circumference measurement and the PWV, should lead to a re-
commendation on the echocardiographic diagnostic to assess wo-
men with diastolic dysfunction before developing symptomatic
HF-PEF.
CONCLUSION
The study data show that pathological aortic PWV values
 9.7 m/s are associated with LV diastolic dysfunction, in ad-
dition to waist circumference >80 cm and the age. The high
prevalence of vascular dysfunction and ASt in a general female
population and the importance of arterial function as a mediator
of myocardial diastolic function support the usefulness of assess-
ment of aortic stiffness as a marker of cardiovascular disease.
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